ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
96,283.26
0.65%
S&P 500
5,998.74
-0.38%
Dow Jones
44,722.06
-0.31%
US Dollar vs Yen
149.8045
-0.91%
Brent Oil
72.855
0.25%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. AQSE
  6. HUTCHMED China Limited (HCM.GB)

  7. HUTCHMED China Limited (HCM.GB) ニュース

HCM.GB

HUTCHMED China (HCM.GB)

HUTCHMED China Limited
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AQSE:HCM.GB
日付受信時刻ニュースソース見出しコード企業名
2023/12/2917 : 30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
2023/12/2917 : 30UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnAQSE:HCM.GBHUTCHMED China Limited
2023/12/2119 : 00UK RegulatoryHutchmed (China) Limited Overseas Regulatory AnnouncementAQSE:HCM.GBHUTCHMED China Limited
2023/12/0719 : 04UK RegulatoryHutchmed (China) Limited Overseas Regulatory AnnouncementAQSE:HCM.GBHUTCHMED China Limited
2023/11/3017 : 30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
2023/11/0916 : 00UK RegulatoryHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM) (fruquintinib)AQSE:HCM.GBHUTCHMED China Limited
2023/10/2417 : 30UK RegulatoryHutchmed (China) Limited Vesting of awards under the LTIPAQSE:HCM.GBHUTCHMED China Limited
2023/09/2917 : 30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
2023/09/1417 : 30UK RegulatoryHutchmed (China) Limited Director's Share DealingAQSE:HCM.GBHUTCHMED China Limited
2023/08/3117 : 30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
2023/08/2115 : 00UK RegulatoryHutchmed (China) Limited Sovleplenib Phase 3 Study Meets Primary EndpointAQSE:HCM.GBHUTCHMED China Limited
2023/08/0717 : 30UK RegulatoryHutchmed (China) Limited Exercise of Share Options by a DirectorAQSE:HCM.GBHUTCHMED China Limited
2023/07/3120 : 00UK RegulatoryHutchmed (China) Limited Interim Results and Business UpdatesAQSE:HCM.GBHUTCHMED China Limited
2023/07/1317 : 30UK RegulatoryHutchmed (China) Limited Changes to Board and Technical CommitteeAQSE:HCM.GBHUTCHMED China Limited
2023/06/2917 : 30UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnAQSE:HCM.GBHUTCHMED China Limited
2023/06/2617 : 30UK RegulatoryHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year ResultsAQSE:HCM.GBHUTCHMED China Limited
2023/06/1615 : 00UK RegulatoryHutchmed (China) Limited Phase III FRESCO-2 Results in The LancetAQSE:HCM.GBHUTCHMED China Limited
2023/06/1523 : 39UK RegulatoryHutchmed (China) Limited MAA of Fruquintinib Validated by the EMAAQSE:HCM.GBHUTCHMED China Limited
2023/06/0618 : 00UK RegulatoryHutchmed (China) Limited LTIP and Share Option SchemeAQSE:HCM.GBHUTCHMED China Limited
2023/05/3117 : 30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
2023/05/2615 : 00UK RegulatoryHutchmed (China) Limited Fruquintinib NDA Granted Priority Review by FDAAQSE:HCM.GBHUTCHMED China Limited
2023/05/1717 : 30UK RegulatoryHutchmed (China) Limited Standard form for notification of major holdingsAQSE:HCM.GBHUTCHMED China Limited
2023/05/1221 : 15UK RegulatoryHutchmed (China) Limited Annual General Meeting Poll ResultsAQSE:HCM.GBHUTCHMED China Limited
2023/05/1217 : 30UK RegulatoryHutchmed (China) Limited Board of Directors and Board Committee MembershipAQSE:HCM.GBHUTCHMED China Limited
2023/05/1017 : 30UK RegulatoryHutchmed (China) Limited Appointment of Independent NEDAQSE:HCM.GBHUTCHMED China Limited
2023/04/2817 : 30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
2023/04/2117 : 30UK RegulatoryHutchmed (China) Limited Vesting of awards under the LTIPAQSE:HCM.GBHUTCHMED China Limited
2023/04/1117 : 30UK RegulatoryHutchmed (China) Limited 2022 Annual Report and Notice of AGMAQSE:HCM.GBHUTCHMED China Limited
2023/04/1117 : 30UK RegulatoryHutchmed (China) Limited Intended Retirement of Independent NEDAQSE:HCM.GBHUTCHMED China Limited
2023/03/3117 : 30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
 Showing the most relevant articles for your search:AQSE:HCM.GB

最近閲覧した銘柄

NYSE
DIS
Walt Disney
FX
USDJPY
US Dollar vs Yen
COIN
BTCUSD
Bitcoin
CCOM
US100
US Tech 100
NYSE
NKE
Nike
NYSE
CVX
Chevron
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
AMEX
XLV
Health Care Select Sector
NYSE
XOM
Exxon Mobil
NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
CCOM
US500
US 500
COIN
ETHUSD
Ethereum
NYSE
MRK
Merck
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有

BLACK FRIDAY

ADVFN

25周年を記念 1999-2024

Forexで最大60%オフ

1年間40％、2年間40％、*3年間60％

*3年間で¥ 153396、たったの¥ 61358